Multicenter study evaluating one multiplex RT-PCR assay to detect SARS-CoV-2, influenza A/B, and respiratory syncytia virus using the LabTurbo AIO open platform : epidemiological features, automated sample-to-result, and high-throughput testing

Since the Coronavirus 19 (COVID-19) pandemic, several SARS-CoV-2 variants of concern (SARS-CoV-2 VOC) have been reported. The B.1.1.7 variant has been associated with increased mortality and transmission risk. Furthermore, cluster and possible co-infection cases could occur in the next influenza season or COVID-19 pandemic wave, warranting efficient diagnosis and treatment decision making. Here, we aimed to detect SARS-CoV-2 and other common respiratory viruses using multiplex RT-PCR developed on the LabTurbo AIO 48 open system. We performed a multicenter study to evaluate the performance and analytical sensitivity of the LabTurbo AIO 48 system for SARS-CoV-2, influenza A/B, and respiratory syncytial virus (RSV) using 652 nasopharyngeal swab clinical samples from patients. The LabTurbo AIO 48 system demonstrated a sensitivity of 9.4 copies/per PCR for N2 of SARS-CoV-2; 24 copies/per PCR for M of influenza A and B; and 24 copies/per PCR for N of RSV. The assay presented consistent performance in the multicenter study. The multiplex RT-PCR applied on the LabTurbo AIO 48 open platform provided highly sensitive, robust, and accurate results and enabled high-throughput detection of B.1.1.7, influenza A/B, and RSV with short turnaround times. Therefore, this automated molecular diagnostic assay could enable streamlined testing if COVID-19 becomes a seasonal disease.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Aging - 13(2021), 23 vom: 12. Dez., Seite 24931-24942

Sprache:

Englisch

Beteiligte Personen:

Chung, Hsing-Yi [VerfasserIn]
Jian, Ming-Jr [VerfasserIn]
Chang, Chih-Kai [VerfasserIn]
Lin, Jung-Chung [VerfasserIn]
Yeh, Kuo-Ming [VerfasserIn]
Yang, Ya-Sung [VerfasserIn]
Chen, Chien-Wen [VerfasserIn]
Hsieh, Shan-Shan [VerfasserIn]
Tang, Sheng-Hui [VerfasserIn]
Perng, Cherng-Lih [VerfasserIn]
Chang, Feng-Yee [VerfasserIn]
Hung, Kuo-Sheng [VerfasserIn]
Chen, En-Sung [VerfasserIn]
Yang, Mei-Hsiu [VerfasserIn]
Shang, Hung-Sheng [VerfasserIn]

Links:

Volltext

Themen:

B.1.1.7 variant
COVID-19
Evaluation Study
Journal Article
Multicenter Study
Multiplex testing
Research Support, Non-U.S. Gov't
SARS-CoV-2
SARS-CoV-2 VOC

Anmerkungen:

Date Completed 04.01.2022

Date Revised 13.12.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.18632/aging.203761

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM334335329